ZDRAVESKI ZORAN — SEC insider filings
SEC reporting owner CIK 1741285. 11 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2021-02-16 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 4,716 shares, $35,255 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 164,686 shares, $952,116 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 164,686 shares @ $5.78 ($952,116) in TScan Therapeutics, Inc., filed 2024-08-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | See Remarks | 10 | 1 leg · 4,716 sh · $35,255 | 1 leg · 164,686 sh · $952,116 | 17 |
| Magenta Therapeutics, Inc. (MGTA) | See Remarks | 1 | — | — | 1 |
Insider filings — ZDRAVESKI ZORAN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2026-01-22 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 52,500 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | TScan Therapeutics, Inc. (TCRX) | Option exercise (M): 54,895 @ $4.85 · Option exercise (M): 25,000 @ $3.27 · Option exercise (M): 13,125 @ $1.81 · Option exercise (M): 64,166 @ $2.49 · Sale (S): 164,686 @ $5.78 · Option exercise (M): 54,895 (derivative) @ $0 · +3 more | EDGAR |
| 2023-06-15 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 430,000 (derivative) @ $0 | EDGAR |
| 2023-02-06 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2022-07-27 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2021-09-27 | 4 | TScan Therapeutics, Inc. (TCRX) | Purchase (P): 4,716 @ $7.48 | EDGAR |
| 2021-09-09 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-02-16 | 4 | Magenta Therapeutics, Inc. (MGTA) | Grant/award (A): 67,700 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1741285 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs